메뉴 건너뛰기




Volumn 30, Issue 9, 1996, Pages 941-945

Evaluation of symptom distress in a bone marrow transplant outpatient environment

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ONDANSETRON; PROCHLORPERAZINE;

EID: 0029791061     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000904     Document Type: Article
Times cited : (31)

References (8)
  • 1
    • 0028147847 scopus 로고
    • The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer
    • Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K, et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol 1994;21 (suppl 7):25-31.
    • (1994) Semin Oncol , vol.21 , Issue.7 SUPPL. , pp. 25-31
    • Peters, W.P.1    Ross, M.2    Vredenburgh, J.J.3    Hussein, A.4    Rubin, P.5    Dukelow, K.6
  • 2
    • 0024270188 scopus 로고
    • High dose combination alkylating agents with bone marrow support as initial treatment of metastatic breast cancer
    • Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, et al. High dose combination alkylating agents with bone marrow support as initial treatment of metastatic breast cancer. J Clin Oncol 1988;6: 1368-76.
    • (1988) J Clin Oncol , vol.6 , pp. 1368-1376
    • Peters, W.P.1    Shpall, E.J.2    Jones, R.B.3    Olsen, G.A.4    Bast, R.C.5    Gockerman, J.P.6
  • 3
    • 0027414795 scopus 로고
    • Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy
    • Beck T, Cheekily AA, Jones SE, Harvey WH. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. Ann Intern Med 1993;118:407-13.
    • (1993) Ann Intern Med , vol.118 , pp. 407-413
    • Beck, T.1    Cheekily, A.A.2    Jones, S.E.3    Harvey, W.H.4
  • 4
    • 0025745215 scopus 로고
    • Progress in the control of acute and delayed emesis induced by cisplatin
    • Gandara DR. Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 1991;27(suppl 1):S9-11.
    • (1991) Eur J Cancer , vol.27 , Issue.1 SUPPL.
    • Gandara, D.R.1
  • 5
    • 0024373276 scopus 로고
    • Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population
    • Lindley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. J Clin Oncol 1989;7:1142-9.
    • (1989) J Clin Oncol , vol.7 , pp. 1142-1149
    • Lindley, C.M.1    Bernard, S.2    Fields, S.M.3
  • 6
    • 0025781590 scopus 로고
    • Introduction: The clinical challenge
    • Schmoll HJ. Introduction: the clinical challenge. Eur J Cancer 1991;27 (suppl 1):S1-2.
    • (1991) Eur J Cancer , vol.27 , Issue.1 SUPPL.
    • Schmoll, H.J.1
  • 7
    • 0018023522 scopus 로고
    • Development of a Symptom Distress Scale
    • McCorkle R, Young K. Development of a Symptom Distress Scale. Cancer Nurs 1978;1:373-8.
    • (1978) Cancer Nurs , vol.1 , pp. 373-378
    • McCorkle, R.1    Young, K.2
  • 8
    • 0026708065 scopus 로고
    • Oral ondansetron for the control of delayed emesis after cisplatin
    • Kris MG, Tyson LB, Clark RA, Gralla RJ. Oral ondansetron for the control of delayed emesis after cisplatin. Cancer 1992;70(suppl 4):1012-6.
    • (1992) Cancer , vol.70 , Issue.4 SUPPL. , pp. 1012-1016
    • Kris, M.G.1    Tyson, L.B.2    Clark, R.A.3    Gralla, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.